Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)

Recruiting now

Conditions studied: Asthma, Asthma Patients, Asthma Bronchiale

In brief

The mainstay of asthma treatment are ICSs, mostly combined with LABA. In the past decade LAMA had been accepted as an add-on treatment for patients at GINA steps 4 and 5. Recently, RCTs proved the efficacy and safety of fixed triple combinations of moderate and high dose of ICS and LABA, LAMA in a very selected asthmatic population, resulting in the market authorisation of these products. However, there is a lack of evidence on the real-world effectiveness of these therapies, especially with regards to improvement in symptom scores and adherence.

Key facts

Study ID
NCT07489911
Run by
Chiesi Slovenija, d.o.o.
People needed
200
Starts
2024-11-04
Expected to finish
2026-07-01
Last updated by the study team
2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.